Tag Archives: Covaxin

Active cases had been on a steady decline and stood at 5,16,632 on Saturday: Ministry of Health There were 577 deaths from COVID-19 in the last 24 hours in the country, and of these, 10 states / UT accounted for almost 83% of the deaths, according to a statement issued …

The February launch would make Bharat Biotech’s Covid vaccine the first Indian-made vaccine to be launched New Delhi: An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, …

A launch in February would make COVAXIN the first Indian-made vaccine to be launched (Representational) New Delhi: India moved forward with work on its coronavirus vaccine, while Britain’s AstraZeneca said its deliveries were being delayed “a bit” as countries around the world sought to conquer the pandemic and rescue their …

A government-backed Covid-19 vaccine could launch in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, a senior scientist told Reuters. government level. Bharat Biotech, a private company developing COVAXIN with the government-run Council of Indian …

New Delhi: An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, a scientist from high level of government. Bharat Biotech, a private company developing COVAXIN with the …

The third phase of the human trial of the indigenously developed COVID-19 ‘Covaxin’ vaccine will soon begin at the Institute of Medical Sciences (IMS) and SUM Hospital in Odisha. IMS and SUM Hospital are on the list of 21 medical institutes selected across the country by the Indian Council for …

Amid the race to develop a ‘potential’ vaccine against the novel coronavirus pandemic, the first Covid-19 vaccine developed in India, Covaxin will soon begin its Phase III clinical trials at a private hospital in Bhubaneswar, an official said. The search for a suitable vaccine for Covid-19 has almost reached the …

Written by Prabha Raghavan | New Delhi | Updated: October 24, 2020 7:52:13 am Covaxin: the country’s first indigenous vaccine is an inactivated one created from the infectious virus strain SARS-CoV-2. BHARAT BIOTECH, who has received approval for late stage human trials for its Covid vaccine candidate, it expects to …

Bharat Biotech plans to conduct the third phase of trials with more than 20,000 volunteers in 12-14 states in India. Bharat Biotech’s own coronavirus vaccine from India, which was in the second stage of human clinical trials, has finally received the go-ahead for the last phase. The highly anticipated candidate …

HYDERABAD: Bharat Biotech, which is developing India’s first indigenous Covid-19 vaccine, Covaxin, expects critical Phase III trials to be completed after April 2021. Only after that will the company apply for the commercial license and WHO prequalification, a senior company official said. However, Covaxin could be available for emergency use …